{"slideshow_credits": null, "snippet": "The group of experts endorsed a close version of the cancer drug Neupogen, which could open the door to more such biosimilar medicines.", "abstract": "Food and Drug Administration panel recommends approval of EP2006, more affordable version of cancer therapy drug Neupogen, also called filgrastim; if FDA acts on recommendation it will create era of competition for so-called biologic drugs, which are made out of living cells rather than synthesized from chemicals.", "section_name": "Science", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 1, "organization": ""}], "original": "By SABRINA TAVERNISE", "contributor": "Andrew Pollack contributed reporting from Los Angeles."}, "web_url": "http://www.nytimes.com/2015/01/08/science/fda-panel-vote-biologics.html", "lead_paragraph": "The group of experts endorsed a close version of the cancer drug Neupogen, which could open the door to more such biosimilar medicines.", "headline": {"main": "For First Time, F.D.A. Panel Approves Generic Copy of Costly Biologic Drug ", "print_headline": "For First Time, F.D.A. Panel Approves Generic Copy of Costly Biologic Drug"}, "_id": "54ad726f38f0d817e02e6e0e", "word_count": "822", "multimedia": [{"height": 126, "url": "images/2015/01/08/business/08FDA/08FDA-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/01/08/business/08FDA/08FDA-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2015/01/08/business/08FDA/08FDA-articleLarge.jpg", "legacy": {"xlarge": "images/2015/01/08/business/08FDA/08FDA-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/01/08/business/08FDA/08FDA-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2015/01/08/business/08FDA/08FDA-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-01-08T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Generic Brands and Products", "is_major": "Y", "rank": "3"}, {"name": "glocations", "value": "United States", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}